Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Aspirin increases bleeding risk in patients receiving warfarin

While patients taking aspirin and warfarin were at a higher risk of a bleeding event compared with those taking only warfarin, the rate of thrombotic events was similar between the two groups.

Some patients receiving anticoagulants may be at increased risk of bleeding owing to concomitant aspirin use, the authors of a study in JAMA Internal Medicine have warned (online, 4 March 2019)[1].

Data included 1,844 patients receiving warfarin and aspirin without a relevant clinical indication for combined therapy matched to an equal number receiving warfarin alone.

After one year, 26.0% of those receiving aspirin with warfarin had a bleeding event, compared with 20.3% in those only receiving warfarin. The rate of major bleeding events was also significantly higher at 5.7% versus 3.3%.

However, the rate of thrombotic events was similar between the two groups, at 2.3% and 2.7%, respectively.

The researchers said that patients may end up on both drugs when they receive care from different medical specialities. But, combined aspirin and warfarin is only recommended in a few circumstances, such as recent acute coronary syndrome.

“Clinicians should ask their patients who are anticoagulated with warfarin if they’re taking aspirin as well,” said lead author Jordan Schaefer from the University of Michigan.

“For the patients who are on both therapies, clinicians should review their medical history to determine if it’s really necessary to be on both drugs.”

Citation: Clinical Pharmacist DOI: 10.1211/CP.2019.20206302

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.